Skip to main content

Ross Taylor

Equibles does not estimate personal net worth.

About Ross Taylor

Ross Taylor was last confirmed as CFO at Codexis, Inc. (CDXS) in a filing dated April 28, 2022. The proxy statement of Codexis, Inc. reports total compensation of $1,264,192 for Ross Taylor in fiscal 2021, including a base salary of $408,270. Disclosed compensation is on record for 5 fiscal years. Ross Taylor has spoken on 11 earnings calls across 1 company, most recently for Codexis, Inc. on November 3, 2022. The companies whose calls Ross Taylor spoke on are classified in the Healthcare sector.

Ross Taylor on recent calls

“Let me dive into our third quarter 2022 financial results, which are summarized here. Total revenues for the third quarter of 2022 were $34.5 million, a decrease of 6% from the prior year period.”
CFO, Codexis, Inc. Q3 FY2022 Earnings Call ·
“Let me dive into our second quarter 2022 financial results, which are summarized on Slide 11. Total revenues for the second quarter of 2022 were $38.4 million, an increase of 51% from the prior-year period.”
CFO, Codexis, Inc. Q2 FY2022 Earnings Call ·
“We delivered strong first-quarter 2022 results. Total revenues for the first quarter of 2022 were $35.3 million, up 96% compared to the prior year period. On a segment basis, $33.1 million in revenue was from the Performance Enzymes segment, and $2.2 million was from Novel Biotherapeutics.”
CFO, Codexis, Inc. Q1 FY2022 Earnings Call ·
“We delivered incredibly strong results in 2021. Starting with the fourth quarter. Total revenues were $24.5 million, up 16% compared to the prior year period. On a segment basis, $22.1 million was from the Performance Enzymes segment and $2.4 million was from Novel Biotherapeutics.”
CFO, Codexis, Inc. Q4 FY2021 Earnings Call ·
“We delivered strong third quarter 2021 results. Total revenues for the third quarter of 2021 were $36.8 million, up 100% compared to the prior year period. On a segment basis, $32.6 million in revenue was from our performance enzyme segment and $4.2 million was from our novel biotherapeutic segment.”
CFO, Codexis, Inc. Q3 FY2021 Earnings Call ·

Affiliation history

  • Codexis, Inc. (CDXS)

    CFO

    Proxy statement

    Start not stated–2022-04-28

    Last confirmed by a filing; no departure on record

Company network

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2021 Codexis, Inc. (CDXS) $408,270 $1,264,192
2020 Codexis, Inc. (CDXS) $406,923 $833,528
2019 Codexis, Inc. (CDXS) $148,862 $479,564
2018 Codexis, Inc. (CDXS) — —
2017 Codexis, Inc. (CDXS) — —

Recent activity